<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34073630</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5673</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22115673</ELocationID><Abstract><AbstractText>Motor neuron diseases (MNDs) are neurodegenerative disorders characterized by upper and/or lower MN loss. MNDs include amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and spinal and bulbar muscular atrophy (SBMA). Despite variability in onset, progression, and genetics, they share a common skeletal muscle involvement, suggesting that it could be a primary site for MND pathogenesis. Due to the key role of muscle-specific microRNAs (myomiRs) in skeletal muscle development, by real-time PCR we investigated the expression of miR-206, miR-133a, miR-133b, and miR-1, and their target genes, in G93A-SOD1 ALS, &#x394;7SMA, and KI-SBMA mouse muscle during disease progression. Further, we analyzed their expression in serum of <i>SOD1</i>-mutated ALS, SMA, and SBMA patients, to demonstrate myomiR role as noninvasive biomarkers. Our data showed a dysregulation of myomiRs and their targets, in ALS, SMA, and SBMA mice, revealing a common pathogenic feature associated with muscle impairment. A similar myomiR signature was observed in patients' sera. In particular, an up-regulation of miR-206 was identified in both mouse muscle and serum of human patients. Our overall findings highlight the role of myomiRs as promising biomarkers in ALS, SMA, and SBMA. Further investigations are needed to explore the potential of myomiRs as therapeutic targets for MND treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malacarne</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9208-021X</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PhD Program in Neuroscience, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galbiati</LastName><ForeName>Mariarita</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3250-5591</Identifier><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, Via Balzaretti, 9, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giagnorio</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PhD Program in Neuroscience, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavalcante</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salerno</LastName><ForeName>Franco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0811-4443</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreetta</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cagnoli</LastName><ForeName>Cinza</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6863-6687</Identifier><AffiliationInfo><Affiliation>Molecular Neuroanatomy and Pathogenesis Unit, Neurology VII-Clinical and Experimental Epileptology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taiana</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Via Francesco Sforza 35, 20122 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nizzardo</LastName><ForeName>Monica</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5447-0882</Identifier><AffiliationInfo><Affiliation>Neurology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corti</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Via Francesco Sforza 35, 20122 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pensato</LastName><ForeName>Viviana</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-9798-2669</Identifier><AffiliationInfo><Affiliation>Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venerando</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gellera</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenu</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit of Rare Neurodegenerative and Neurometabolic Diseases, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pareyson</LastName><ForeName>Davide</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-6854-765X</Identifier><AffiliationInfo><Affiliation>Unit of Rare Neurodegenerative and Neurometabolic Diseases, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masson</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9311-452X</Identifier><AffiliationInfo><Affiliation>Developmental Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maggi</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0932-5173</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalla Bella</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauria</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Via G.B. Grassi 74, 20157 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantegazza</LastName><ForeName>Renato</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9810-5737</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernasconi</LastName><ForeName>Pia</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0869-2104</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poletti</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8883-0468</Identifier><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, Via Balzaretti, 9, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonanno</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8823-6821</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcuzzo</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2015-2020</GrantID><Agency>Italian Ministry of Health</Agency><Country/></Grant><Grant><GrantID>2015-0023</GrantID><Agency>FRRB TRANS-ALS</Agency><Country/></Grant><Grant><GrantID>2017-1886</GrantID><Agency>CARIPLO</Agency><Country/></Grant><Grant><GrantID>GGP14039 AND GGP19128</GrantID><Agency>FONDAZIONE TELETHON</Agency><Country/></Grant><Grant><GrantID>ALS-HSPB8, ALS-GRANULOPATHY, MLOPATHY, TARGET-RAN</GrantID><Agency>FONDAZIONE ARISLA</Agency><Country/></Grant><Grant><GrantID>2015LFPNMN, 2017 F2A2C5</GrantID><Agency>PRIN-PROGETTI DI RICERCA DI INTARESSE NAZIONALE</Agency><Country/></Grant><Grant><GrantID>PROGETTO DIPARTIMENTI DI ECCELLENZA</GrantID><Agency>ITALIAN MINISTRY OF UNIVERSITY AND RESEARCH</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C109415">SOD1 G93A protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="Y">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">motor neuron diseases</Keyword><Keyword MajorTopicYN="N">mouse models</Keyword><Keyword MajorTopicYN="N">muscle-specific microRNAs</Keyword><Keyword MajorTopicYN="N">spinal bulbar muscular atrophy</Keyword><Keyword MajorTopicYN="N">spinal muscular atrophy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>1</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34073630</ArticleId><ArticleId IdType="pmc">PMC8198536</ArticleId><ArticleId IdType="doi">10.3390/ijms22115673</ArticleId><ArticleId IdType="pii">ijms22115673</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Chalabi A., Visscher P.M. Motor neuron disease: Common genetic variants and the heritability of ALS. Nat. Rev. Neurol. 2014;10:549&#x2013;550. doi: 10.1038/nrneurol.2014.166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.166</ArticleId><ArticleId IdType="pubmed">25201239</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M., Dion P.A., Rouleau G.A. ALS: Recent Developments from Genetics Studies. Curr. Neurol. Neurosci. Rep. 2016;16:1&#x2013;12. doi: 10.1007/s11910-016-0658-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-016-0658-1</ArticleId><ArticleId IdType="pubmed">27113253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L.C., Leigh P.N. Amyotrophic lateral sclerosis. Orphanet. J. Rare. Dis. 2009;4:3. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw P.J. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J. Neurol. Neurosurg. Psychiatry. 2005;76:1046&#x2013;1057. doi: 10.1136/jnnp.2004.048652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2004.048652</ArticleId><ArticleId IdType="pmc">PMC1739758</ArticleId><ArticleId IdType="pubmed">16024877</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland D.W., Rothstein J.D. From charcot to lou gehrig: Deciphering selective motor neuron death in als. Nat. Rev. Neurosci. 2001;2:806&#x2013;819. doi: 10.1038/35097565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Shaw P.J. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free. Radic. Biol. Med. 2010;48:629&#x2013;641. doi: 10.1016/j.freeradbiomed.2009.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolb S.J., Kissel J.T. Spinal Muscular Atrophy. Neurol. Clin. 2015;33:831&#x2013;846. doi: 10.1016/j.ncl.2015.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.004</ArticleId><ArticleId IdType="pmc">PMC4628728</ArticleId><ArticleId IdType="pubmed">26515624</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubitz A.K., Feng W., Dreyfuss G. The SMN complex. Exp. Cell Res. 2004;296:51&#x2013;56. doi: 10.1016/j.yexcr.2004.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2004.03.022</ArticleId><ArticleId IdType="pubmed">15120993</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowerman M., Murray L.M., Scamps F., Schneider B.L., Kothary R., Raoul C. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development. Eur. J. Med. Genet. 2018;61:685&#x2013;698. doi: 10.1016/j.ejmg.2017.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2017.12.001</ArticleId><ArticleId IdType="pubmed">29313812</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosolini A.P., Sleigh J.N. Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2017;10:405. doi: 10.3389/fnmol.2017.00405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00405</ArticleId><ArticleId IdType="pmc">PMC5725447</ArticleId><ArticleId IdType="pubmed">29270111</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nat. Cell Biol. 1991;352:77&#x2013;79. doi: 10.1038/352077a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes C.J., Ling S.-C., Guo L.T., Hung G., Tsunemi T., Ly L., Tokunaga S., Lopez E., Sopher B.L., Bennett C.F., et al. Muscle Expression of Mutant Androgen Receptor Accounts for Systemic and Motor Neuron Disease Phenotypes in Spinal and Bulbar Muscular Atrophy. Neuron. 2014;82:295&#x2013;307. doi: 10.1016/j.neuron.2014.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.03.001</ArticleId><ArticleId IdType="pmc">PMC4096235</ArticleId><ArticleId IdType="pubmed">24742458</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P., Bolzoni E., Crippa V., Onesto E., Sau D., Galbiati M., Piccolella M., Poletti A. Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy. Neurobiol. Dis. 2010;40:361&#x2013;369. doi: 10.1016/j.nbd.2010.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.06.016</ArticleId><ArticleId IdType="pubmed">20621188</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P., Polanco M.J., Cristofani R., Cicardi M.E., Meroni M., Galbiati M., Piccolella M., Messi E., Giorgetti E., Lieberman A.P., et al. Aberrant Autophagic Response in The Muscle of a Knock-in Mouse Model of Spinal and Bulbar Muscular Atrophy. Sci. Rep. 2015;5:15174. doi: 10.1038/srep15174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15174</ArticleId><ArticleId IdType="pmc">PMC4614888</ArticleId><ArticleId IdType="pubmed">26490709</ArticleId></ArticleIdList></Reference><Reference><Citation>Galbiati M., Crippa V., Rusmini P., Cristofani R., Cicardi M.E., Giorgetti E., Onesto E., Messi E., Poletti A. ALS-related misfolded protein management in motor neurons and muscle cells. Neurochem. Int. 2014;79:70&#x2013;78. doi: 10.1016/j.neuint.2014.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2014.10.007</ArticleId><ArticleId IdType="pubmed">25451799</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S., Zucca I., Mastropietro A., de Rosbo N.K., Cavalcante P., Tartari S., Bonanno S., Preite L., Mantegazza R., Bernasconi P. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyo-trophic lateral sclerosis: A longitudinal MRI study. Exp. Neurol. 2014;231:30&#x2013;37. doi: 10.1016/j.expneurol.2011.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.05.007</ArticleId><ArticleId IdType="pubmed">21620832</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S., Bonanno S., Figini M., Scotti A., Zucca I., Minati L., Riva N., Domi T., Fossaghi A., Quattrini A., et al. A longitudinal DTI and histological study of the spinal cord reveals early pathological alterations in G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2017;293:43&#x2013;52. doi: 10.1016/j.expneurol.2017.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.03.018</ArticleId><ArticleId IdType="pubmed">28351750</ArticleId></ArticleIdList></Reference><Reference><Citation>Valsecchi V., Boido M., De Amicis E., Piras A., Vercelli A. Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model. PLoS ONE. 2015;10:e0128560. doi: 10.1371/journal.pone.0128560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0128560</ArticleId><ArticleId IdType="pmc">PMC4450876</ArticleId><ArticleId IdType="pubmed">26030275</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Thisted R.A., Appel S.H., Bradley W.G., Olney R.K., Berg J.E., Pope L.E., Smith R.A., AVP-923 ALS Study Group Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: A randomized trial. Neurology. 2004;63:1364&#x2013;1370. doi: 10.1212/01.WNL.0000142042.50528.2F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000142042.50528.2F</ArticleId><ArticleId IdType="pubmed">15505150</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu A.Y., Zhai P., Canto M.C.D., Peters T.M., Kwon Y.W., Prattis S.M., Gurney M.E. Age-Dependent Penetrance of Disease in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis. Mol. Cell. Neurosci. 1995;6:349&#x2013;362. doi: 10.1006/mcne.1995.1027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.1995.1027</ArticleId><ArticleId IdType="pubmed">8846004</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Echaniz-Laguna A. Skeletal Muscle in Motor Neuron Diseases: Therapeutic Target and Delivery Route for Potential Treatments. Curr. Drug Targets. 2010;11:1250&#x2013;1261. doi: 10.2174/1389450111007011250.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450111007011250</ArticleId><ArticleId IdType="pmc">PMC4834127</ArticleId><ArticleId IdType="pubmed">20840067</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and Selective Loss of Neuromuscular Synapse Subtypes with Low Sprouting Competence in Motoneuron Diseases. J. Neurosci. 2000;20:2534&#x2013;2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Bonconpagni S., Belia S., Wannenes F., Nicoletti C., Del Prete Z., et al. Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M., Martin L.J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010;19:2284&#x2013;2302. doi: 10.1093/hmg/ddq106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq106</ArticleId><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler J.-P., Picchiarelli G., Dupuis L., De Aguilar J.-L.G. The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis. Brain Pathol. 2016;26:227&#x2013;236. doi: 10.1111/bpa.12350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12350</ArticleId><ArticleId IdType="pmc">PMC8029271</ArticleId><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Lotti F., Dittmar K., Younis I., Wan L., Kasim M., Dreyfuss G. SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in Splicing. Cell. 2008;133:585&#x2013;600. doi: 10.1016/j.cell.2008.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.03.031</ArticleId><ArticleId IdType="pmc">PMC2446403</ArticleId><ArticleId IdType="pubmed">18485868</ArticleId></ArticleIdList></Reference><Reference><Citation>Giavazzi A., Setola V., Simonati A., Battaglia G. Neuronal-specific roles of the survival motor neuron protein: Evidence from survival motor neuron expression patterns in the developing human central nervous system. J. Neuropathol. Exp. Neurol. 2006;65:267&#x2013;277. doi: 10.1097/01.jnen.0000205144.54457.a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000205144.54457.a3</ArticleId><ArticleId IdType="pubmed">16651888</ArticleId></ArticleIdList></Reference><Reference><Citation>Setola V., Terao M., Locatelli D., Bassanini S., Garattini E., Battaglia G. Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis. Proc. Natl. Acad. Sci. USA. 2007;104:1959&#x2013;1964. doi: 10.1073/pnas.0610660104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0610660104</ArticleId><ArticleId IdType="pmc">PMC1794299</ArticleId><ArticleId IdType="pubmed">17261814</ArticleId></ArticleIdList></Reference><Reference><Citation>Fidzia&#x144;ska A., Goebel H.H., Warlo I. Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism. Brain. 1990;113:433&#x2013;445. doi: 10.1093/brain/113.2.433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/113.2.433</ArticleId><ArticleId IdType="pubmed">2328412</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens L., Bastide B., Maurage C.A., Dupont E., Montel V., Cieniewski-Bernard C., Cuisset J.M., Vallee L., Mounier Y. Childhood spinal muscular atrophy induces alterations in contractile and regulatory protein isoform expressions. Neuropathol. Appl. Neurobiol. 2008;34:659&#x2013;670. doi: 10.1111/j.1365-2990.2008.00950.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2008.00950.x</ArticleId><ArticleId IdType="pubmed">18363640</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Errico P., Boido M., Piras A., Valsecchi V., De Amicis E., Locatelli D., Capra S., Vagni F., Vercelli A., Battaglia G. Selective vulnerability of spinal and cortical motor neuron subpopulations in delta7 SMA mice. PLoS ONE. 2013;8:e82654. doi: 10.1371/journal.pone.0082654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082654</ArticleId><ArticleId IdType="pmc">PMC3855775</ArticleId><ArticleId IdType="pubmed">24324819</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicole S., Desforges B., Millet G., Lesbordes J., Diaz C.C., Vertes D., Cao M.L., De Backer F., Languille L., Roblot N., et al. Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle. J. Cell Biol. 2003;161:571&#x2013;582. doi: 10.1083/jcb.200210117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200210117</ArticleId><ArticleId IdType="pmc">PMC2172949</ArticleId><ArticleId IdType="pubmed">12743106</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafey D., C&#xf4;t&#xe9; P.D., Kothary R. Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Exp. Cell Res. 2005;311:49&#x2013;61. doi: 10.1016/j.yexcr.2005.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2005.08.019</ArticleId><ArticleId IdType="pubmed">16219305</ArticleId></ArticleIdList></Reference><Reference><Citation>Park G.-H., Kariya S., Monani U.R. Spinal Muscular Atrophy: New and Emerging Insights from Model Mice. Curr. Neurol. Neurosci. Rep. 2010;10:108&#x2013;117. doi: 10.1007/s11910-010-0095-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-010-0095-5</ArticleId><ArticleId IdType="pmc">PMC2861773</ArticleId><ArticleId IdType="pubmed">20425235</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayzullina S., Martin L.J. Skeletal Muscle DNA Damage Precedes Spinal Motor Neuron DNA Damage in a Mouse Model of Spinal Muscular Atrophy (SMA) PLoS ONE. 2014;9:e93329. doi: 10.1371/journal.pone.0093329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093329</ArticleId><ArticleId IdType="pmc">PMC3965546</ArticleId><ArticleId IdType="pubmed">24667816</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo K., Razak Z., Rao P., Yu Z., Adachi H., Katsuno M., Sobue G., Lieberman A.P., Westwood J.T., Monks D.A. Microarray Analysis of Gene Expression by Skeletal Muscle of Three Mouse Models of Kennedy Disease/Spinal Bulbar Muscular Atrophy. PLoS ONE. 2010;5:e12922. doi: 10.1371/journal.pone.0012922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012922</ArticleId><ArticleId IdType="pmc">PMC2944863</ArticleId><ArticleId IdType="pubmed">20886071</ArticleId></ArticleIdList></Reference><Reference><Citation>Malena A., Pennuto M., Tezze C., Querin G., D&#x2019;Ascenzo C., Silani V., Cenacchi G., Scaramozza A., Romito S., Morandi L., et al. Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. Acta Neuropathol. 2013;126:109&#x2013;121. doi: 10.1007/s00401-013-1122-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1122-9</ArticleId><ArticleId IdType="pubmed">23644820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramzan F., McPhail M., Rao P., Mo K., Halievski K., Swift-Gallant A., Mendoza-Viveros L., Cheng H.Y., Monks D.A. Distinct Etiological Roles for Myocytes and Motor Neurons in a Mouse Model of Kennedy&#x2019;s Disease/Spinobulbar Muscular Atrophy. J. Neurosci. 2015;35:6444&#x2013;6451. doi: 10.1523/JNEUROSCI.3599-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3599-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605215</ArticleId><ArticleId IdType="pubmed">25904795</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Dadgar N., Allbertelli M., Gruis K., Jordan C., Robins D.M., Lieberman A.P. Androgen dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Investig. 2006;116:2663&#x2013;2672. doi: 10.1172/JCI28773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI28773</ArticleId><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Chivet M., Marchioretti C., Pirazzini M., Piol D., Scaramuzzino C., Polanco M.J., Romanello V., Zuccaro E., Parodi S., D&#x2019;Antonio M., et al. Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism. Cells. 2020;9:325. doi: 10.3390/cells9020325.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9020325</ArticleId><ArticleId IdType="pmc">PMC7072234</ArticleId><ArticleId IdType="pubmed">32019272</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman A.P., Yu Z., Murray S., Peralta R., Low A., Guo S., Yu X.X., Cortes C.J., Bennett C.F., Monia B.P., et al. Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy. Cell Rep. 2014;7:774&#x2013;784. doi: 10.1016/j.celrep.2014.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.02.008</ArticleId><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Haramati S., Chapnik E., Sztainberg Y., Eilam R., Zwang R., Gershoni N., McGlinn E., Heiser P.W., Wills A.-M., Wirguin I., et al. miRNA malfunction causes spinal motor neuron disease. Proc. Natl. Acad. Sci. USA. 2010;107:13111&#x2013;13116. doi: 10.1073/pnas.1006151107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006151107</ArticleId><ArticleId IdType="pmc">PMC2919953</ArticleId><ArticleId IdType="pubmed">20616011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kye M.J., Gon&#xe7;alves I.C. The role of miRNA in motor neuron disease. Front. Cell Neurosci. 2014;8:15. doi: 10.3389/fncel.2014.00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00015</ArticleId><ArticleId IdType="pmc">PMC3906579</ArticleId><ArticleId IdType="pubmed">24523674</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., Wang D.Z. The Role of MicroRNA-1 and MicroRNA-133 in Skeletal Muscle Proliferation and Differentiation. Nat. Genet. 2005;38:228&#x2013;233. doi: 10.1038/ng1725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1725</ArticleId><ArticleId IdType="pmc">PMC2538576</ArticleId><ArticleId IdType="pubmed">16380711</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.-F., Callis T.E., Wang D.-Z. microRNAs and muscle disorders. J. Cell Sci. 2009;122:13&#x2013;20. doi: 10.1242/jcs.041723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.041723</ArticleId><ArticleId IdType="pmc">PMC2714401</ArticleId><ArticleId IdType="pubmed">19092056</ArticleId></ArticleIdList></Reference><Reference><Citation>Horak M., Novakab J., Bienertova-Vaskuac J. Muscle-specific microRNAs in skeletal muscle development. Dev. Biol. 2016;410:1&#x2013;13. doi: 10.1016/j.ydbio.2015.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2015.12.013</ArticleId><ArticleId IdType="pubmed">26708096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y., Chen J. MicroRNAs in skeletal myogenesis. Cell Cycle. 2011;10:441&#x2013;448. doi: 10.4161/cc.10.3.14710.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.10.3.14710</ArticleId><ArticleId IdType="pmc">PMC3115018</ArticleId><ArticleId IdType="pubmed">21270519</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.-F., Tao Y., Li J., Deng Z., Yan Z., Xiao X., Wang D. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J. Cell Biol. 2010;190:867&#x2013;879. doi: 10.1083/jcb.200911036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200911036</ArticleId><ArticleId IdType="pmc">PMC2935565</ArticleId><ArticleId IdType="pubmed">20819939</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole F., Zhang W., Geyra A., Kang J.-S., Krauss R.S. Positive Regulation of Myogenic bHLH Factors and Skeletal Muscle Development by the Cell Surface Receptor CDO. Dev. Cell. 2004;7:843&#x2013;854. doi: 10.1016/j.devcel.2004.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2004.10.009</ArticleId><ArticleId IdType="pubmed">15572127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma G., Wang Y., Li Y., Cui L., Zhao Y., Zhao B., Li K. MiR-206, a Key Modulator of Skeletal Muscle Development and Disease. Int. J. Biol. Sci. 2015;11:345&#x2013;352. doi: 10.7150/ijbs.10921.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.10921</ArticleId><ArticleId IdType="pmc">PMC4323374</ArticleId><ArticleId IdType="pubmed">25678853</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Nelson B.R., Bezprozvannaya S., Shelton J.M., Richardson J.A., Bassel-Duby R., Olson E.N. Requirement of MEF2A, C, and D for skeletal muscle regeneration. Proc. Natl. Acad. Sci. USA. 2014;111:4109&#x2013;4114. doi: 10.1073/pnas.1401732111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1401732111</ArticleId><ArticleId IdType="pmc">PMC3964114</ArticleId><ArticleId IdType="pubmed">24591619</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A., Leonardis L., Zidar J., Koritnik B., Dolenc-Groselj L., Kovacic S.R., Curk T., Rogelj B. Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci. Rep. 2018;8:5609. doi: 10.1038/s41598-018-23139-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23139-2</ArticleId><ArticleId IdType="pmc">PMC5884852</ArticleId><ArticleId IdType="pubmed">29618798</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasca E., Pegoraro V., Merico A., Angelini C. Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS. Clin. Neuropathol. 2016;35:22&#x2013;30. doi: 10.5414/NP300889.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300889</ArticleId><ArticleId IdType="pubmed">26588026</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V., Marozzo R., Angelini C. MicroRNAs and HDAC4 protein expression in the skeletal muscle of ALS patients. Clin. Neuropathol. 2020;39:105&#x2013;114. doi: 10.5414/NP301233.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP301233</ArticleId><ArticleId IdType="pubmed">32000889</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G., Simonet T., Bauch&#xe9; S., Mandjee N., Malfatti E., Girard E., Tanguy M.-L., B&#xe9;hin A., Khiami F., Sariali E., et al. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: Potential role in reinnervation ability and disease progression. Brain. 2013;136:2359&#x2013;2368. doi: 10.1093/brain/awt164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt164</ArticleId><ArticleId IdType="pubmed">23824486</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y., Cui X., Crossman D.K., Hao J., Kazamel M., Kwon Y., King P.H. Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis. Neurobiol. Dis. 2018;114:85&#x2013;94. doi: 10.1016/j.nbd.2018.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.02.009</ArticleId><ArticleId IdType="pmc">PMC5891369</ArticleId><ArticleId IdType="pubmed">29486297</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanno S., Marcuzzo S., Malacarne C., Giagnorio E., Masson R., Zanin R., Arnoldi M.T., Andreetta F., Simoncini O., Venerando A., et al. Circulating MyomiRs as potential biomarkers to monitor response to Nusinersen in pediatric SMA patients. Biomedicines. 2020;8:21. doi: 10.3390/biomedicines8020021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8020021</ArticleId><ArticleId IdType="pmc">PMC7168147</ArticleId><ArticleId IdType="pubmed">31991852</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen J.M., Manzano R., Oliv&#xe1;n S., Zaragoza P., Garc&#xed;a-Redondo A., Osta R. MicroRNA-206: A Potential Circulating Biomarker Candidate for Amyotrophic Lateral Sclerosis. PLoS ONE. 2014;9:e89065. doi: 10.1371/journal.pone.0089065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089065</ArticleId><ArticleId IdType="pmc">PMC3930686</ArticleId><ArticleId IdType="pubmed">24586506</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen L., J&#xf8;rgensen L.H., Bech R.D., Frandsen U., Schr&#xf8;der H.D. Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis. BioMed Res. Int. 2016;2016:1&#x2013;12. doi: 10.1155/2016/5930621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/5930621</ArticleId><ArticleId IdType="pmc">PMC4852332</ArticleId><ArticleId IdType="pubmed">27195289</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V., Merico A., Angelini C. Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration. J. Neurol. Sci. 2017;380:58&#x2013;63. doi: 10.1016/j.jns.2017.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.07.008</ArticleId><ArticleId IdType="pmc">PMC5598142</ArticleId><ArticleId IdType="pubmed">28870590</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweep H., Sticht C., Pandey P., Gretz N. miRWalk-database: Prediction of possible miRNA binding sites by &#x201c;walking&#x201d; the genes of three genomes. J. Biomed. Inform. 2011;44:839&#x2013;847. doi: 10.1016/j.jbi.2011.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2011.05.002</ArticleId><ArticleId IdType="pubmed">21605702</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Kumar R.M., Penn B.H., Berkes C.A., Kooperberg C., Boyer L.A., Young R.A., Tapscott S.J. Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. EMBO J. 2006;25:502&#x2013;511. doi: 10.1038/sj.emboj.7600958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600958</ArticleId><ArticleId IdType="pmc">PMC1383539</ArticleId><ArticleId IdType="pubmed">16437161</ArticleId></ArticleIdList></Reference><Reference><Citation>Du C., Jin Y.Q., Qi J.J., Ji Z.X., Li S.Y., An G.S., Jia H.T., Ni J.H. Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin. Mol. Cells. 2012;34:133&#x2013;142. doi: 10.1007/s10059-012-2286-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10059-012-2286-1</ArticleId><ArticleId IdType="pmc">PMC3887822</ArticleId><ArticleId IdType="pubmed">22814845</ArticleId></ArticleIdList></Reference><Reference><Citation>Meroni M., Crippa V., Cristofani R., Rusmini P., Cicardi M.E., Messi E., Piccolella M., Tedesco B., Ferrari V., Sorar&#xf9; G., et al. Transforming growth factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients. Neurobiol. Aging. 2019;82:48&#x2013;59. doi: 10.1016/j.neurobiolaging.2019.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.07.001</ArticleId><ArticleId IdType="pubmed">31394426</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy J.J. The MyomiR Network in Skeletal Muscle Plasticity. Exerc. Sport Sci. Rev. 2011;39:150&#x2013;154. doi: 10.1097/JES.0b013e31821c01e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JES.0b013e31821c01e1</ArticleId><ArticleId IdType="pmc">PMC4871711</ArticleId><ArticleId IdType="pubmed">21467943</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro L., Baranzini M., Berardinelli M.G., Lattanzi W., Monforte M., Tasca G., Conte A., Logroscino G., Michetti F., Ricci E., et al. Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients. Sci. Rep. 2017;7:9538. doi: 10.1038/s41598-017-10161-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10161-z</ArticleId><ArticleId IdType="pmc">PMC5573384</ArticleId><ArticleId IdType="pubmed">28842714</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinchetti P., Rizzuti M., Faravelli I., Corti S. MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2017;55:2617&#x2013;2630. doi: 10.1007/s12035-017-0537-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0537-z</ArticleId><ArticleId IdType="pubmed">28421535</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalanotto C., Cogoni C., Zardo G. MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions. Int. J. Mol. Sci. 2016;17:1712. doi: 10.3390/ijms17101712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17101712</ArticleId><ArticleId IdType="pmc">PMC5085744</ArticleId><ArticleId IdType="pubmed">27754357</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz G., Zamboni F., Tice A., Farci P. Integrated ordination of miRNA and mRNA expression profiles. BMC Genom. 2015;16:1&#x2013;13. doi: 10.1186/s12864-015-1971-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-015-1971-9</ArticleId><ArticleId IdType="pmc">PMC4603994</ArticleId><ArticleId IdType="pubmed">26459852</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao P.K., Kumar R.M., Farkhondeh M., Baskerville S., Lodish H.F. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl. Acad. Sci. USA. 2006;103:8721&#x2013;8726. doi: 10.1073/pnas.0602831103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602831103</ArticleId><ArticleId IdType="pmc">PMC1482645</ArticleId><ArticleId IdType="pubmed">16731620</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A.C., Manzano R., Atencia-Cibreiro G., Oliv&#xe1;n S., Mu&#xf1;oz M.J., Zaragoza P., Cordero-V&#xe1;zquez P., Esteban-P&#xe9;rez J., Garc&#xed;a-Redondo A., Osta R. Genetic Biomarkers for ALS Disease in Transgenic SOD1G93A Mice. PLoS ONE. 2012;7:e32632. doi: 10.1371/journal.pone.0032632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032632</ArticleId><ArticleId IdType="pmc">PMC3296719</ArticleId><ArticleId IdType="pubmed">22412900</ArticleId></ArticleIdList></Reference><Reference><Citation>Catapano F., Zaharieva I., Scoto M., Marrosu E., Morgan J., Muntoni F., Zhou H. Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy. Mol. Ther. Nucleic Acids. 2016;5:e331. doi: 10.1038/mtna.2016.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mtna.2016.47</ArticleId><ArticleId IdType="pmc">PMC5014531</ArticleId><ArticleId IdType="pubmed">27377135</ArticleId></ArticleIdList></Reference><Reference><Citation>Borisov A.B., Carlson B.M. Cell death in denervated skeletal muscle is distinct from classical apoptosis. Anat. Rec. 2000;258:305&#x2013;318. doi: 10.1002/(SICI)1097-0185(20000301)258:3&lt;305::AID-AR10&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0185(20000301)258:3&lt;305::AID-AR10&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">10705351</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacchiarelli D., Legnini I., Martone J., Cazzella V., D&#x2019;Amico A., Bertini E., Bozzoni I. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol. Med. 2011;3:258&#x2013;265. doi: 10.1002/emmm.201100133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201100133</ArticleId><ArticleId IdType="pmc">PMC3112257</ArticleId><ArticleId IdType="pubmed">21425469</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V., Merico A., Angelini C. MyomiRNAs Dysregulation in ALS Rehabilitation. Brain Sci. 2019;9:8. doi: 10.3390/brainsci9010008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci9010008</ArticleId><ArticleId IdType="pmc">PMC6356197</ArticleId><ArticleId IdType="pubmed">30634563</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Le T.T., Pham L.T., Butchbach M.E., Zhang H.L., Monani U.R., Coovert D.D., Gavrilina T.O., Xing L., Bassell G.J., Burghes A.H. SMN&#x394;7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum. Mol. Genet. 2005;14:845&#x2013;857. doi: 10.1093/hmg/ddi078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi078</ArticleId><ArticleId IdType="pubmed">15703193</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Bai Z., Han W., Zhang J., Meng H., Bi J., Ma X., Han S., Zhang Z. Identification of Suitable Reference Genes for qPCR Analysis of Serum microRNA in Gastric Cancer Patients. Dig. Dis. Sci. 2011;57:897&#x2013;904. doi: 10.1007/s10620-011-1981-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-011-1981-7</ArticleId><ArticleId IdType="pubmed">22198701</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>